Singapore (SG)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium (2021) Morra A, Jung AY, Behrens S, Keeman R, Ahearn TU, Anton-Culver H, Arndt V, et al. Journal article Half-Auxeticity and Anisotropic Transport in Pd Decorated Two-Dimensional Boron Sheets (2021) Ma F, Jiao Y, Wu W, Liu Y, Yang SA, Heine T Journal article Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group (2021) Moreau P, Kumar SK, San Miguel J, Davies F, Zamagni E, Bahlis N, Ludwig H, et al. Journal article, Review article Mutations in PRDM15 are a novel cause of galloway-mowat syndrome (2021) Mann N, Mzoughi S, Schneider R, Kuhl SJ, Schanze D, Klambt V, Lovric S, et al. Journal article What every reader should know about studies using electronic health record data but may be afraid to ask (2021) Kohane IS, Aronow BJ, Avillach P, Beaulieu-Jones BK, Bellazzi R, Bradford RL, Brat GA, et al. Journal article, Review article The transmembrane protein tetraspanin 5 controls the effects of loss of the tumor suppressor deleted in liver cancer 1 (DLC1) on hepatocellular carcinoma (HCC) growth (2021) Schreyer L, Mittermeier C, Martin DE, Singer S, Liebl B, Gudermann T, Aigner A, Mühlich S Conference contribution Pseudoexfoliation syndrome and glaucoma: from genes to disease mechanisms (2021) Schlötzer-Schrehardt U, Khor CC Journal article, Review article Association of Rare CYP39A1 Variants with Exfoliation Syndrome Involving the Anterior Chamber of the Eye (2021) Li Z, Wang Z, Lee MC, Zenkel M, Peh E, Ozaki M, Topouzis F, et al. Journal article Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women (2021) Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Luccarini C, Wahlstrom C, Pooley KA, et al. Journal article Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor plus (HR plus ) metastatic breast cancer (MBC) who have previously received a taxane (2021) O'Shaughnessy J, Schwartzberg L, Piccart M, Rugo HS, Yardley DA, Cortes J, Untch M, et al. Conference contribution